17
Dec 2025
New tool can predict recurrence risk in patients with pancreatic neuroendocrine tumors
Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients with pancreatic neuroendocrine tumors (PanNETs) need closer monitoring because their cancer is more likely to recur.